Leica Biosystems, AstraZeneca and Daiichi Sankyo have expanded their strategic collaboration to develop an AI-enabled immunohistochemistry assay and computational pathology solution for evaluating the TROP2 Normalised Membrane Ratio biomarker in NSCLC, aiming to advance biomarker-driven cancer research and future precision medicine approaches.<br />
Digital Pathology | 01/06/2026 | By News Bureau | 109
Boston Cell Standards Advances Cancer Testing Tools into FDA Qualification Phase
Boston Cell Standards moves closer to standardising cancer diagnostics as its IHC reference tools enter FDA qualification, aiming to improve accuracy and accelerate therapy development.
Digital Pathology | 29/04/2026 | By News Bureau
Sectra Enters Japan's Digital Pathology Market with Kameda Medical Centre Project
Sectra brings AI-enabled digital pathology workflows to Kameda Medical Centre in partnership with Matsunami Glass.
Digital Pathology | 07/01/2026 | By News Bureau | 366
AIxMed and PathNet Partner to Advance Digital Pathology with AI-Driven Urine Cytology
AIxMed has partnered with PathNet to advance digital pathology through its AIxURO solution, an AI-powered platform designed to enhance the analysis of non-invasive urine cytology samples. The collaboration aims to boost diagnostic accuracy and streamline workflows in bladder cancer detection.
Digital Pathology | 04/11/2025 | By Dineshwori | 262
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy